▶ 調査レポート

アミノグリコシド系抗生物質の世界市場レポート2020

• 英文タイトル:Global Aminoglycoside Antibiotics Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。アミノグリコシド系抗生物質の世界市場レポート2020 / Global Aminoglycoside Antibiotics Sales Market Report 2020 / 20QY06-00682資料のイメージです。• レポートコード:20QY06-00682
• 出版社/出版日:QYResearch / 2020年6月3日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、135ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、アミノグリコシド系抗生物質のグローバル市場について種類別(ネオマイシン、トブラマイシン、ゲンタマイシン、アミカシン、パロモマイシン、カナマイシン)、用途別(獣医、呼吸器、UTIおよび骨盤疾患、新生児敗血症)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・アミノグリコシド系抗生物質市場の概要
・世界の主要地域別アミノグリコシド系抗生物質市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のアミノグリコシド系抗生物質市場規模2015-2026:種類別(ネオマイシン、トブラマイシン、ゲンタマイシン、アミカシン、パロモマイシン、カナマイシン)
・世界のアミノグリコシド系抗生物質市場規模2015-2026:用途別(獣医、呼吸器、UTIおよび骨盤疾患、新生児敗血症)
・アミノグリコシド系抗生物質の北米市場規模2015-2020
・アミノグリコシド系抗生物質のヨーロッパ市場規模2015-2020
・アミノグリコシド系抗生物質の中国市場規模2015-2020
・アミノグリコシド系抗生物質の日本市場規模2015-2020
・アミノグリコシド系抗生物質の東南アジア市場規模2015-2020
・アミノグリコシド系抗生物質のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Britannica、Novartis Pharmaceuticals、Merck、Kremoint Pharma、Medson Pharmaceuticals、Allergan)
・アミノグリコシド系抗生物質の製造コスト分析
・販売チャネル、流通業者、顧客
・アミノグリコシド系抗生物質の市場動向・機会・課題
・調査の結論

Market Analysis and Insights: Global Aminoglycoside Antibiotics Market
The global Aminoglycoside Antibiotics market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Aminoglycoside Antibiotics Scope and Market Size
The global Aminoglycoside Antibiotics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Aminoglycoside Antibiotics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Aminoglycoside Antibiotics market is segmented into
Neomycin
Tobramycin
Gentamicin
Amikacin
Paromomycin
Kanamycin

Segment by Application, the Aminoglycoside Antibiotics market is segmented into
Veterinary
Respiratory
UTI & Pelvic Disease
Neonatal Sepsis
The Aminoglycoside Antibiotics market is analysed and market size information is provided by regions (countries). Segment by Application, the Aminoglycoside Antibiotics market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Aminoglycoside Antibiotics Market Share Analysis
Aminoglycoside Antibiotics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Aminoglycoside Antibiotics business, the date to enter into the Aminoglycoside Antibiotics market, Aminoglycoside Antibiotics product introduction, recent developments, etc.
The major vendors covered:
Britannica
Novartis Pharmaceuticals
Merck
Kremoint Pharma
Medson Pharmaceuticals
Allergan

レポート目次

Table of Contents

1 Aminoglycoside Antibiotics Market Overview
1.1 Aminoglycoside Antibiotics Product Scope
1.2 Aminoglycoside Antibiotics Segment by Type
1.2.1 Global Aminoglycoside Antibiotics Sales by Type (2020-2026)
1.2.2 Neomycin
1.2.3 Tobramycin
1.2.4 Gentamicin
1.2.5 Amikacin
1.2.6 Paromomycin
1.2.7 Kanamycin
1.3 Aminoglycoside Antibiotics Segment by Application
1.3.1 Global Aminoglycoside Antibiotics Sales Comparison by Application (2020-2026)
1.3.2 Veterinary
1.3.3 Respiratory
1.3.4 UTI & Pelvic Disease
1.3.5 Neonatal Sepsis
1.4 Aminoglycoside Antibiotics Market Estimates and Forecasts (2015-2026)
1.4.1 Global Aminoglycoside Antibiotics Sales Growth Rate (2015-2026)
1.4.2 Global Aminoglycoside Antibiotics Revenue and Growth Rate (2015-2026)
1.4.3 Global Aminoglycoside Antibiotics Price Trends (2015-2026)

2 Aminoglycoside Antibiotics Estimate and Forecast by Region
2.1 Global Aminoglycoside Antibiotics Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Aminoglycoside Antibiotics Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Aminoglycoside Antibiotics Sales Market Share by Region (2015-2020)
2.2.2 Global Aminoglycoside Antibiotics Revenue Market Share by Region (2015-2020)
2.3 Global Aminoglycoside Antibiotics Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Aminoglycoside Antibiotics Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Aminoglycoside Antibiotics Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Aminoglycoside Antibiotics Estimates and Projections (2015-2026)
2.4.2 Europe Aminoglycoside Antibiotics Estimates and Projections (2015-2026)
2.4.3 China Aminoglycoside Antibiotics Estimates and Projections (2015-2026)
2.4.4 Japan Aminoglycoside Antibiotics Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Aminoglycoside Antibiotics Estimates and Projections (2015-2026)
2.4.6 India Aminoglycoside Antibiotics Estimates and Projections (2015-2026)
3 Global Aminoglycoside Antibiotics Competition Landscape by Players
3.1 Global Top Aminoglycoside Antibiotics Players by Sales (2015-2020)
3.2 Global Top Aminoglycoside Antibiotics Players by Revenue (2015-2020)
3.3 Global Aminoglycoside Antibiotics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Aminoglycoside Antibiotics as of 2019)
3.4 Global Aminoglycoside Antibiotics Average Price by Company (2015-2020)
3.5 Manufacturers Aminoglycoside Antibiotics Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Aminoglycoside Antibiotics Players (Opinion Leaders)
4 Global Aminoglycoside Antibiotics Market Size by Type
4.1 Global Aminoglycoside Antibiotics Historic Market Review by Type (2015-2020)
4.1.1 Global Aminoglycoside Antibiotics Sales Market Share by Type (2015-2020)
4.1.2 Global Aminoglycoside Antibiotics Revenue Market Share by Type (2015-2020)
4.1.3 Global Aminoglycoside Antibiotics Price by Type (2014-2020)
4.2 Global Aminoglycoside Antibiotics Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Aminoglycoside Antibiotics Sales Forecast by Type (2021-2026)
4.2.2 Global Aminoglycoside Antibiotics Revenue Forecast by Type (2021-2026)
4.2.3 Global Aminoglycoside Antibiotics Price Forecast by Type (2021-2026)
5 Global Aminoglycoside Antibiotics Market Size by Application
5.1 Global Aminoglycoside Antibiotics Historic Market Review by Application (2015-2020)
5.1.1 Global Aminoglycoside Antibiotics Sales Market Share by Application (2015-2020)
5.1.2 Global Aminoglycoside Antibiotics Revenue Market Share by Application (2015-2020)
5.1.3 Global Aminoglycoside Antibiotics Price by Application (2015-2020)
5.2 Global Aminoglycoside Antibiotics Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Aminoglycoside Antibiotics Sales Forecast by Application (2021-2026)
5.2.2 Global Aminoglycoside Antibiotics Revenue Forecast by Application (2021-2026)
5.2.3 Global Aminoglycoside Antibiotics Price Forecast by Application (2021-2026)

3 North America Aminoglycoside Antibiotics Market Facts & Figures
3.2 North America Aminoglycoside Antibiotics Sales Market Share by Company (2015-2020)
3.3 North America Aminoglycoside Antibiotics Sales Market Share by Type (2015-2020)
3.4 North America Aminoglycoside Antibiotics Sales Market Share by Application (2015-2020)

4 Europe Aminoglycoside Antibiotics Market Facts & Figures
4.2 Europe Aminoglycoside Antibiotics Sales Market Share by Company (2015-2020)
4.3 Europe Aminoglycoside Antibiotics Sales Market Share by Type (2015-2020)
4.4 Europe Aminoglycoside Antibiotics Sales Market Share by Application (2015-2020)

5 China Aminoglycoside Antibiotics Market Facts & Figures
5.2 China Aminoglycoside Antibiotics Sales Market Share by Company (2015-2020)
5.3 China Aminoglycoside Antibiotics Sales Market Share by Type (2015-2020)
5.4 China Aminoglycoside Antibiotics Sales Market Share by Application (2015-2020)

6 Japan Aminoglycoside Antibiotics Market Facts & Figures
6.2 Japan Aminoglycoside Antibiotics Sales Market Share by Company (2015-2020)
6.3 Japan Aminoglycoside Antibiotics Sales Market Share by Type (2015-2020)
6.4 Japan Aminoglycoside Antibiotics Sales Market Share by Application (2015-2020)

7 Southeast Asia Aminoglycoside Antibiotics Market Facts & Figures
7.2 Southeast Asia Aminoglycoside Antibiotics Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Aminoglycoside Antibiotics Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Aminoglycoside Antibiotics Sales Market Share by Application (2015-2020)

8 India Aminoglycoside Antibiotics Market Facts & Figures
8.2 India Aminoglycoside Antibiotics Sales Market Share by Company (2015-2020)
8.3 India Aminoglycoside Antibiotics Sales Market Share by Type (2015-2020)
8.4 India Aminoglycoside Antibiotics Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Aminoglycoside Antibiotics Business
12.1 Britannica
12.1.1 Britannica Aminoglycoside Antibiotics Corporation Information
12.1.2 Britannica Aminoglycoside Antibiotics Business Overview and Total Revenue
12.1.3 Britannica Aminoglycoside Antibiotics Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Britannica Aminoglycoside Antibiotics Products Offered
12.1.5 Britannica Recent Development
12.2 Novartis Pharmaceuticals
12.2.1 Novartis Pharmaceuticals Aminoglycoside Antibiotics Corporation Information
12.2.2 Novartis Pharmaceuticals Aminoglycoside Antibiotics Business Overview and Total Revenue
12.2.3 Novartis Pharmaceuticals Aminoglycoside Antibiotics Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis Pharmaceuticals Aminoglycoside Antibiotics Products Offered
12.2.5 Novartis Pharmaceuticals Recent Development
12.3 Merck
12.3.1 Merck Aminoglycoside Antibiotics Corporation Information
12.3.2 Merck Aminoglycoside Antibiotics Business Overview and Total Revenue
12.3.3 Merck Aminoglycoside Antibiotics Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck Aminoglycoside Antibiotics Products Offered
12.3.5 Merck Recent Development
12.4 Kremoint Pharma
12.4.1 Kremoint Pharma Aminoglycoside Antibiotics Corporation Information
12.4.2 Kremoint Pharma Aminoglycoside Antibiotics Business Overview and Total Revenue
12.4.3 Kremoint Pharma Aminoglycoside Antibiotics Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Kremoint Pharma Aminoglycoside Antibiotics Products Offered
12.4.5 Kremoint Pharma Recent Development
12.5 Medson Pharmaceuticals
12.5.1 Medson Pharmaceuticals Aminoglycoside Antibiotics Corporation Information
12.5.2 Medson Pharmaceuticals Aminoglycoside Antibiotics Business Overview and Total Revenue
12.5.3 Medson Pharmaceuticals Aminoglycoside Antibiotics Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Medson Pharmaceuticals Aminoglycoside Antibiotics Products Offered
12.5.5 Medson Pharmaceuticals Recent Development
12.6 Allergan
12.6.1 Allergan Aminoglycoside Antibiotics Corporation Information
12.6.2 Allergan Aminoglycoside Antibiotics Business Overview and Total Revenue
12.6.3 Allergan Aminoglycoside Antibiotics Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Allergan Aminoglycoside Antibiotics Products Offered
12.6.5 Allergan Recent Development

13 Aminoglycoside Antibiotics Manufacturing Cost Analysis
13.1 Aminoglycoside Antibiotics Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Aminoglycoside Antibiotics
13.4 Aminoglycoside Antibiotics Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Aminoglycoside Antibiotics Distributors List
14.3 Aminoglycoside Antibiotics Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables

Table 1. Global Aminoglycoside Antibiotics Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Aminoglycoside Antibiotics Sales (K Units) Comparison by Application (2020-2026)
Table 3. Global Market Aminoglycoside Antibiotics Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Aminoglycoside Antibiotics Sales (K Units) by Region (2015-2020)
Table 5. Global Aminoglycoside Antibiotics Sales Market Share by Region (2015-2020)
Table 6. Global Aminoglycoside Antibiotics Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Aminoglycoside Antibiotics Revenue Share by Region (2015-2020)
Table 8. Global Aminoglycoside Antibiotics Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Aminoglycoside Antibiotics Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Aminoglycoside Antibiotics Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Aminoglycoside Antibiotics Revenue Share Forecast by Region (2021-2026)
Table 12. Global Aminoglycoside Antibiotics (K Units) of Key Companies (2015-2020)
Table 13. Global Aminoglycoside Antibiotics Sales Share by Company (2015-2020)
Table 14. Global Aminoglycoside Antibiotics Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Aminoglycoside Antibiotics Revenue Share by Company (2015-2020)
Table 16. Global Aminoglycoside Antibiotics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Aminoglycoside Antibiotics as of 2019)
Table 17. Global Aminoglycoside Antibiotics Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Aminoglycoside Antibiotics Manufacturing Sites and Area Served
Table 19. Manufacturers Aminoglycoside Antibiotics Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Aminoglycoside Antibiotics Players
Table 22. Global Aminoglycoside Antibiotics Sales (K Units) by Type (2015-2020)
Table 23. Global Aminoglycoside Antibiotics Sales Share by Type (2015-2020)
Table 24. Global Aminoglycoside Antibiotics Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Aminoglycoside Antibiotics Price (K Units) by Type (2015-2020)
Table 26. Global Aminoglycoside Antibiotics Sales Share by Type (2021-2026)
Table 27. Global Aminoglycoside Antibiotics Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Aminoglycoside Antibiotics Revenue Share by Type (2021-2026)
Table 29. Global Aminoglycoside Antibiotics Price (K Units) by Type (2021-2026)
Table 30. Global Aminoglycoside Antibiotics Sales (K Units) by Application (2015-2020)
Table 31. Global Aminoglycoside Antibiotics Sales Share by Application (2015-2020)
Table 32. Global Aminoglycoside Antibiotics Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Aminoglycoside Antibiotics Price (K Units) by Application (2015-2020)
Table 34. Global Aminoglycoside Antibiotics Sales (K Units) by Application (2021-2026)
Table 35. Global Aminoglycoside Antibiotics Sales Share by Application (2021-2026)
Table 36. Global Aminoglycoside Antibiotics Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Aminoglycoside Antibiotics Revenue Share by Application (2021-2026)
Table 38. Global Aminoglycoside Antibiotics Price (K Units) by Application (2021-2026)
Table 39. United States Aminoglycoside Antibiotics Sales (K Units) by Company (2015-2020)
Table 40. United States Aminoglycoside Antibiotics Sales Market Share by Company (2015-2020)
Table 41. United States Aminoglycoside Antibiotics Sales (K Units) by Type (2015-2020)
Table 42. United States Aminoglycoside Antibiotics Sales Market Share by Type (2015-2020)
Table 43. United States Aminoglycoside Antibiotics Sales (K Units) by Application (2015-2020)
Table 44. United States Aminoglycoside Antibiotics Sales Market Share by Application (2015-2020)
Table 45. Europe Aminoglycoside Antibiotics Sales (K Units) by Company (2015-2020)
Table 46. Europe Aminoglycoside Antibiotics Sales Market Share by Company (2015-2020)
Table 47. Europe Aminoglycoside Antibiotics Sales (K Units) by Type (2015-2020)
Table 48. Europe Aminoglycoside Antibiotics Sales Market Share by Type (2015-2020)
Table 49. Europe Aminoglycoside Antibiotics Sales (K Units) by Application (2015-2020)
Table 50. Europe Aminoglycoside Antibiotics Sales Market Share by Type (2015-2020)
Table 51. China Aminoglycoside Antibiotics Sales (K Units) by Company (2015-2020)
Table 52. China Aminoglycoside Antibiotics Sales Market Share by Company (2015-2020)
Table 53. China Aminoglycoside Antibiotics Sales (K Units) by Type (2015-2020)
Table 54. China Aminoglycoside Antibiotics Sales Market Share by Type (2015-2020)
Table 55. China Aminoglycoside Antibiotics Sales (K Units) by Application (2015-2020)
Table 56. China Aminoglycoside Antibiotics Sales Market Share by Application (2015-2020)
Table 57. Japan Aminoglycoside Antibiotics Sales (K Units) by Company (2015-2020)
Table 58. Japan Aminoglycoside Antibiotics Sales Market Share by Company (2015-2020)
Table 59. Japan Aminoglycoside Antibiotics Sales (K Units) by Type (2015-2020)
Table 60. Japan Aminoglycoside Antibiotics Sales Market Share by Type (2015-2020)
Table 61. Japan Aminoglycoside Antibiotics Sales (K Units) by Application (2015-2020)
Table 62. Japan Aminoglycoside Antibiotics Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Aminoglycoside Antibiotics Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Aminoglycoside Antibiotics Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Aminoglycoside Antibiotics Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Aminoglycoside Antibiotics Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Aminoglycoside Antibiotics Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Aminoglycoside Antibiotics Sales Market Share by Application (2015-2020)
Table 69. India Aminoglycoside Antibiotics Sales (K Units) by Company (2015-2020)
Table 70. India Aminoglycoside Antibiotics Sales Market Share by Company (2015-2020)
Table 71. India Aminoglycoside Antibiotics Sales (K Units) by Type (2015-2020)
Table 72. India Aminoglycoside Antibiotics Sales Market Share by Type (2015-2020)
Table 73. India Aminoglycoside Antibiotics Sales (K Units) by Application (2015-2020)
Table 74. India Aminoglycoside Antibiotics Sales Market Share by Application (2015-2020)
Table 75. Britannica Corporation Information
Table 76. Britannica Description and Business Overview
Table 77. Britannica Aminoglycoside Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Britannica Aminoglycoside Antibiotics Product
Table 79. Britannica Recent Development
Table 80. Novartis Pharmaceuticals Corporation Information
Table 81. Novartis Pharmaceuticals Description and Business Overview
Table 82. Novartis Pharmaceuticals Aminoglycoside Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Novartis Pharmaceuticals Aminoglycoside Antibiotics Product
Table 84. Novartis Pharmaceuticals Recent Development
Table 85. Merck Corporation Information
Table 86. Merck Description and Business Overview
Table 87. Merck Aminoglycoside Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Merck Aminoglycoside Antibiotics Product
Table 89. Merck Recent Development
Table 90. Kremoint Pharma Corporation Information
Table 91. Kremoint Pharma Description and Business Overview
Table 92. Kremoint Pharma Aminoglycoside Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Kremoint Pharma Aminoglycoside Antibiotics Product
Table 94. Kremoint Pharma Recent Development
Table 95. Medson Pharmaceuticals Corporation Information
Table 96. Medson Pharmaceuticals Description and Business Overview
Table 97. Medson Pharmaceuticals Aminoglycoside Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Medson Pharmaceuticals Aminoglycoside Antibiotics Product
Table 99. Medson Pharmaceuticals Recent Development
Table 100. Allergan Corporation Information
Table 101. Allergan Description and Business Overview
Table 102. Allergan Aminoglycoside Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Allergan Aminoglycoside Antibiotics Product
Table 104. Allergan Recent Development
Table 105. Production Base and Market Concentration Rate of Raw Material
Table 106. Key Suppliers of Raw Materials
Table 107. Aminoglycoside Antibiotics Distributors List
Table 108. Aminoglycoside Antibiotics Customers List
Table 109. Market Key Trends
Table 110. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 111. Key Challenges
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Aminoglycoside Antibiotics Product Picture
Figure 2. Global Aminoglycoside Antibiotics Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Aminoglycoside Antibiotics Market Share by Application in 2020 & 2026
Figure 6. Veterinary Examples
Figure 7. Respiratory Examples
Figure 8. UTI & Pelvic Disease Examples
Figure 9. Neonatal Sepsis Examples
Figure 10. Global Aminoglycoside Antibiotics Sales (K Units) Growth Rate (2015-2026)
Figure 11. Global Aminoglycoside Antibiotics Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Aminoglycoside Antibiotics Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 13. Global Aminoglycoside Antibiotics Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Aminoglycoside Antibiotics Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Aminoglycoside Antibiotics Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Aminoglycoside Antibiotics Sales (K Units) Growth Rate (2015-2026)
Figure 17. Europe Aminoglycoside Antibiotics Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Aminoglycoside Antibiotics Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Aminoglycoside Antibiotics Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Aminoglycoside Antibiotics Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Aminoglycoside Antibiotics Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Aminoglycoside Antibiotics Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Aminoglycoside Antibiotics Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Aminoglycoside Antibiotics Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Aminoglycoside Antibiotics Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Aminoglycoside Antibiotics Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Aminoglycoside Antibiotics Players Market Share by Revenue in Aminoglycoside Antibiotics 2015 & 2019
Figure 28. Aminoglycoside Antibiotics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Aminoglycoside Antibiotics Revenue Share by Type (2015-2020)
Figure 30. Global Aminoglycoside Antibiotics Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Aminoglycoside Antibiotics Revenue Share by Application (2015-2020)
Figure 32. Global Aminoglycoside Antibiotics Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Aminoglycoside Antibiotics Sales Market Share by Type in 2019
Figure 34. United States Aminoglycoside Antibiotics Sales Market Share by Type in 2019
Figure 35. Europe Aminoglycoside Antibiotics Sales Market Share by Company in 2019
Figure 36. Europe Aminoglycoside Antibiotics Sales Market Share by Type in 2019
Figure 37. Europe Aminoglycoside Antibiotics Sales Market Share by Application in 2019
Figure 38. China Aminoglycoside Antibiotics Sales Market Share by Company in 2019
Figure 39. China Aminoglycoside Antibiotics Sales Market Share by Type in 2019
Figure 40. China Aminoglycoside Antibiotics Sales Market Share by Application in 2019
Figure 41. Japan Aminoglycoside Antibiotics Sales Market Share by Company in 2019
Figure 42. Japan Aminoglycoside Antibiotics Sales Market Share by Type in 2019
Figure 43. Japan Aminoglycoside Antibiotics Sales Market Share by Application in 2019
Figure 44. Southeast Asia Aminoglycoside Antibiotics Sales Market Share by Company in 2019
Figure 45. Southeast Asia Aminoglycoside Antibiotics Sales Market Share by Type in 2019
Figure 46. Southeast Asia Aminoglycoside Antibiotics Sales Market Share by Application in 2019
Figure 47. India Aminoglycoside Antibiotics Sales Market Share by Company in 2019
Figure 48. India Aminoglycoside Antibiotics Sales Market Share by Type in 2019
Figure 49. India Aminoglycoside Antibiotics Sales Market Share by Application in 2019
Figure 50. Britannica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Novartis Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Kremoint Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Medson Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of Aminoglycoside Antibiotics
Figure 58. Manufacturing Process Analysis of Aminoglycoside Antibiotics
Figure 59. Aminoglycoside Antibiotics Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Porter's Five Forces Analysis
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed